Cargando…

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer, with increasing prevalence worldwide. The mortality rate of HCC is similar to its incidence rate, which reflects its poor prognosis. At present, the diagnosis of HCC is still mostly dependent on invasive biopsy, imag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wei, Tan, Hor Yue, Wang, Ning, Wang, Xuanbin, Feng, Yibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903488/ https://www.ncbi.nlm.nih.gov/pubmed/29692630 http://dx.doi.org/10.2147/CMAR.S156837

Ejemplares similares

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
por: Guo, Wei, et al.
Publicado: (2019)

The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy
por: Chen, Feiyu, et al.
Publicado: (2020)

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease
por: Li, Sha, et al.
Publicado: (2019)

New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma
por: Tan, Hor-Yue, et al.
Publicado: (2016)

Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells
por: Wang, Ning, et al.
Publicado: (2016)

Chinese Medicines Induce Cell Death: The Molecular and Cellular Mechanisms for Cancer Therapy
por: Wang, Xuanbin, et al.
Publicado: (2014)

The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases
por: Tan, Hor-Yue, et al.
Publicado: (2016)

Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth—A Small Molecule Inhibitor, Berberine
por: Guo, Wei, et al.
Publicado: (2020)

Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
por: Wu, Xingyun, et al.
Publicado: (2023)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
por: Huang, Jihan, et al.
Publicado: (2020)

Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective
por: Guo, Wei, et al.
Publicado: (2022)

Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials
por: Cheung, Fan, et al.
Publicado: (2013)

IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma
por: Tan, Hor-Yue, et al.
Publicado: (2016)

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
por: Wang, Xuanbin, et al.
Publicado: (2016)

Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p
por: Chen, Feiyu, et al.
Publicado: (2020)

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review
por: Feng, Ningning, et al.
Publicado: (2022)

Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
por: Rashid, Md Mamunur, et al.
Publicado: (2023)

Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF‐1α‐independent VEGF expression and angiogenesis in hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2020)

MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy
por: Hong, Ming, et al.
Publicado: (2015)

Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde
por: Wang, Ning, et al.
Publicado: (2017)

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
por: Yang, Nian, et al.
Publicado: (2019)

CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
por: Chan, Yau-Tuen, et al.
Publicado: (2022)

Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
por: Wu, Junyu, et al.
Publicado: (2023)

The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
por: Yuan, Hongchao, et al.
Publicado: (2021)

Metabolomics for Biomarker Discovery: Moving to the Clinic
por: Zhang, Aihua, et al.
Publicado: (2015)

Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
por: Guo, Wei, et al.
Publicado: (2020)

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020)

Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells
por: Wang, Ning, et al.
Publicado: (2021)

Atg9b Deficiency Suppresses Autophagy and Potentiates Endoplasmic Reticulum Stress-Associated Hepatocyte Apoptosis in Hepatocarcinogenesis
por: Wang, Ning, et al.
Publicado: (2017)

The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
por: Wang, Xuanbin, et al.
Publicado: (2015)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

Metabolomics Deciphering the Potential Biomarkers of Hengqing I Prescription against Vascular Dementia
por: Meng, Shengxi, et al.
Publicado: (2022)

Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
por: Hong, Ming, et al.
Publicado: (2015)

Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
por: Lu, Yuanjun, et al.
Publicado: (2022)

The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
por: Jiang, Xue, et al.
Publicado: (2019)

Disease monitoring of hepatocellular carcinoma through metabolomics
por: Fitian, Asem I, et al.
Publicado: (2017)

Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma
por: Xu, Yanzhen, et al.
Publicado: (2021)

Functional metabolomics: from biomarker discovery to metabolome reprogramming
por: Peng, Bo, et al.
Publicado: (2015)

The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
por: Shen, Eric Yi-Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i1c0fou84bauf67avpoo1hra7f